A Case of Alveolar Rhabdomyosarcoma with Multifocal Pyomyositis Following Chemotherapy

Author:

Sharma Vibhor1,Subi TS2,Chaudhary Debashish2,Patel Mehul3

Affiliation:

1. Department of Medical Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, India

2. Department of Surgical Oncology, Homi Bhabha Cancer Hospital, Sangrur, Punjab, India

3. Department of Radiodiagnosis, Homi Bhabha Cancer Hospital, Sangrur, Punjab, India

Abstract

AbstractPyomyositis is extremely rare after chemotherapy for nonhematological malignancies. We report a patient of alveolar rhabdomyosarcoma, who developed multifocal pyomyositis in bilateral lower limbs after the first cycle of neoadjuvant chemotherapy with vincristine, ifosfamide, mesna, and etoposide. The diagnosis of pyomyositis was reached after ultrasound and contrast-enhanced computed tomography scan of bilateral lower limbs. Staphylococcus and Streptococcus were isolated from pus. This patient was treated with 4 weeks of antibiotics, besides ultrasound-guided pus aspiration and open surgical debridement. To the best of our knowledge, no case of rhabdomyosarcoma with pyomyositis following chemotherapy has been reported so far.

Publisher

Georg Thieme Verlag KG

Subject

Oncology,Pediatrics, Perinatology and Child Health

Reference10 articles.

1. Pyomyositis during induction chemotherapy for acute lymphoblastic leukemia;K L Kao;J Chin Med Assoc,2006

2. MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy;T Fukushima;Anticancer Res,2009

3. Stenotrophomonas maltophilia septicemia with pyomyositis in a chemotherapy-treated patient;S H Tsai;Ann Hematol,2003

4. Pyomyositis after chemotherapy for endometrial cancer;P Singh;Int J Gynecol Cancer,2010

5. A case of multiple pyomyositis after chemotherapy for lung cancer;K Yamada;Gan To Kagaku Ryoho,2006

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Etoposide/ifosfamide/vincristine;Reactions Weekly;2018-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3